MONOCLONAL ANTIBODY AGAINST EBAG9, HYBRIDOMA, AND APPLICATION FOR MONOCLONAL ANTIBODY AGAINST EBAG9

摘要

　A monoclonal antibody against EBAG9, said monoclonal antibody being obtained by a method including: a step in which a polypeptide is administered to a mouse as an immunogen, said polypeptide containing the amino acid sequence set forth in SEQ ID No. 1, and not containing the full-length amino acid sequence of EBAG9 protein; a step in which antibody-producing cells are collected from the mouse; a step in which an antibody-producing cell and a myeloma are fused to produce a hybridoma; a step in which an antibody produced by the hybridoma is brought into contact with a polypeptide containing the amino acid sequence set forth in SEQ ID No. 1, and not containing the full-length amino acid sequence of EBAG9 protein, and then a hybridoma is selected that produces an antibody that binds to the polypeptide containing the amino acid sequence set forth in SEQ ID No. 1, and not containing the full-length amino acid sequence of EBAG9 protein; and a step in which antibodies produced by the selected hybridoma are collected.